US Top Rating Updates on 11/15: ATVI, RHHBY, ENPH, FSLR and More

Atlantic Equities analyst Simon Clinch upgraded $Equifax(EFX.US)$ to Overweight from Neutral with a $230 price target following the Q3 results. The "time is fast approaching" when investors can start valuing the stock on fiscal 2024 earnings, Clinch tells investors in a research note. The analyst believes the "mixed" Q3 earnings report had some positive takeaways, such as better structural growth for Equifax.

Cowen analyst Steve Scala downgraded $ROCHE HOLDING AG(RHHBY.US)$ to Market Perform from Outperform with an unchanged price target of $48 following the failure of its Alzheimer's drug Gantenerumab. The news is a "disappointment" and leaves Roche's late-stage pipeline looking "somewhat bare," Scala tells investors in a research note.

Deutsche Bank analyst Corinne Blanchard initiated coverage of $Enphase Energy(ENPH.US)$ with a Buy rating and $330 price target. The analyst's bullish outlook on the solar group is "underpinned by considerable growth opportunities" for the U.S. residential market and the "most powerful and positive regulatory environment the industry has ever seen." Tailwinds will "outshine any short-lived negatives," Blanchard tells investors in a research note.